STOCK TITAN

BD Named One of America's Most Innovative Companies by Fortune

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Very Positive)
Tags

BD (NYSE: BDX), a leading global medical technology company, has been recognized on Fortune's 2025 list of America's Most Innovative Companies, placing in the top 25% overall. The recognition was based on a comprehensive survey of over 40,000 U.S. employees and 2,500 industry experts.

The evaluation focused on three key categories:

  • Product innovation: Introduction of new products and improvement of existing ones, including patent portfolio
  • Process innovation: Development of new technologies and production processes
  • Innovation culture: Fostering entrepreneurship and employee creativity

Tom Polen, chairman, CEO and president of BD, emphasized the company's commitment to innovation as one of the world's largest medical device manufacturers, serving billions of patients globally through their BD Excellence culture of continuous improvement.

BD (NYSE: BDX), una delle principali aziende globali nel settore della tecnologia medica, è stata riconosciuta nella lista 2025 di Fortune delle Aziende più Innovative d'America, posizionandosi nel 25% superiore complessivo. Il riconoscimento si basa su un'ampia indagine condotta su oltre 40.000 dipendenti statunitensi e 2.500 esperti del settore.

L'analisi si è concentrata su tre categorie chiave:

  • Innovazione di prodotto: Introduzione di nuovi prodotti e miglioramento di quelli esistenti, inclusi i portafogli di brevetti
  • Innovazione di processo: Sviluppo di nuove tecnologie e processi produttivi
  • Cultura dell'innovazione: Promozione dell'imprenditorialità e della creatività dei dipendenti

Tom Polen, presidente, CEO e presidente di BD, ha sottolineato l'impegno dell'azienda per l'innovazione come uno dei maggiori produttori di dispositivi medici al mondo, servendo miliardi di pazienti globalmente attraverso la loro cultura di eccellenza BD, dedicata al miglioramento continuo.

BD (NYSE: BDX), una de las principales empresas globales de tecnología médica, ha sido reconocida en la lista 2025 de Fortune de las Empresas Más Innovadoras de América, situándose en el 25% superior en general. El reconocimiento se basó en una encuesta integral de más de 40,000 empleados en EE. UU. y 2,500 expertos de la industria.

La evaluación se centró en tres categorías clave:

  • Innovación de productos: Introducción de nuevos productos y mejora de los existentes, incluyendo la cartera de patentes
  • Innovación de procesos: Desarrollo de nuevas tecnologías y procesos de producción
  • Cultura de innovación: Fomento del emprendimiento y la creatividad de los empleados

Tom Polen, presidente, CEO y director de BD, enfatizó el compromiso de la empresa con la innovación como uno de los mayores fabricantes de dispositivos médicos del mundo, sirviendo a miles de millones de pacientes a nivel global a través de su cultura de excelencia BD de mejora continua.

BD (NYSE: BDX), 세계적인 의료 기술 회사 중 하나로, 포춘의 2025년 미국에서 가장 혁신적인 기업 목록에 올라 전체 상위 25%에 자리 잡았습니다. 이 인식은 40,000명 이상의 미국 직원과 2,500명의 산업 전문가를 대상으로 한 포괄적인 설문 조사에 기반하고 있습니다.

평가는 세 가지 주요 범주에 중점을 두었습니다:

  • 제품 혁신: 새로운 제품의 도입 및 기존 제품의 개선, 특허 포트폴리오 포함
  • 프로세스 혁신: 새로운 기술 및 생산 공정의 개발
  • 혁신 문화: 기업가 정신 및 직원 창의성의 장려

BD의 회장 겸 CEO인 톰 폴렌은 세계 최대 의료 기기 제조업체 중 하나로서 혁신에 대한 회사의 헌신을 강조하며, 지속적인 개선을 위한 BD 우수성 문화를 통해 전 세계 수십억 명의 환자에게 서비스를 제공하고 있다고 전했습니다.

BD (NYSE: BDX), une entreprise mondiale de technologie médicale de premier plan, a été reconnue dans la liste 2025 de Fortune des entreprises les plus innovantes d'Amérique, se classant dans le top 25% au total. Cette reconnaissance repose sur une enquête complète menée auprès de plus de 40 000 employés américains et de 2 500 experts de l'industrie.

L'évaluation s'est concentrée sur trois catégories clés :

  • Innovation produit : Introduction de nouveaux produits et amélioration des produits existants, y compris le portefeuille de brevets
  • Innovation de processus : Développement de nouvelles technologies et de processus de production
  • Culture de l'innovation : Promotion de l'entrepreneuriat et de la créativité des employés

Tom Polen, président, PDG et directeur de BD, a souligné l'engagement de l'entreprise envers l'innovation en tant que l'un des plus grands fabricants de dispositifs médicaux au monde, servant des milliards de patients à l'échelle mondiale grâce à leur culture d'excellence BD axée sur l'amélioration continue.

BD (NYSE: BDX), ein führendes globales Unternehmen im Bereich Medizintechnologie, wurde in der 2025-Liste von Fortune der innovativsten Unternehmen Amerikas anerkannt und gehört zu den obersten 25%. Die Anerkennung basiert auf einer umfassenden Umfrage unter über 40.000 US-Mitarbeitern und 2.500 Branchenexperten.

Die Bewertung konzentrierte sich auf drei Hauptkategorien:

  • Produktinnovation: Einführung neuer Produkte und Verbesserung bestehender Produkte, einschließlich des Patentportfolios
  • Prozessinnovation: Entwicklung neuer Technologien und Produktionsprozesse
  • Innovationskultur: Förderung von Unternehmertum und Kreativität der Mitarbeiter

Tom Polen, Vorsitzender, CEO und Präsident von BD, betonte das Engagement des Unternehmens für Innovation als einer der größten Hersteller von Medizinprodukten weltweit, der Milliarden von Patienten global durch ihre BD-Exzellenzkultur der kontinuierlichen Verbesserung bedient.

Positive
  • None.
Negative
  • None.

FRANKLIN LAKES, N.J., March 31, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's 2025 list of America's Most Innovative Companies, ranking in the top 25% of companies overall. The list recognizes organizations that excel in developing innovative products, streamlining processes, and cultivating a forward-thinking corporate culture.

"As one of the largest manufacturers of medical devices in the world whose products touch billions of patients around the globe, building on our long history of innovation is a responsibility we take very seriously," said Tom Polen, chairman, CEO and president of BD. "Through the ingenuity of our world-class team who strives to address unmet needs in healthcare every day, coupled with BD Excellence - our culture of continuous improvement - we can live our purpose and manufacture innovative medical products at scale as we deliver for our customers and the patients we serve."

Fortune and Statista surveyed more than 40,000 U.S. employees and more than 2,500 industry experts to rank companies across the following three categories:

  1. Product innovation: Regular introduction of new products or services and improvement of existing products and services, in addition to the number and relevance of industrial property rights in the form of patents.
  2. Process innovation: Development and use of new and innovative technologies and production processes, as well as the innovative use of digitalization and the resulting opportunities.
  3. Innovation culture: Extent a company fosters a spirit of entrepreneurship and creativity, encouraging their employees to take initiative and develop new ideas.

For a full list of awards and recognitions BD has received, visit news.bd.com/Award-news.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson

Media:
Jessica Offerjost
BD Public Relations
201-258-0964
jessica.offerjost@bd.com

Investors:
Adam Reiffe
Sr. Director, Investor Relations
201-847-6927
adam.reiffe@bd.com 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-named-one-of-americas-most-innovative-companies-by-fortune-302413488.html

SOURCE BD (Becton, Dickinson and Company)

FAQ

What recognition did BD (BDX) receive from Fortune in 2025?

BD (BDX) was named to Fortune's 2025 list of America's Most Innovative Companies, ranking in the top 25% of companies overall.

How many people were surveyed for Fortune's 2025 innovative companies ranking?

Fortune and Statista surveyed more than 40,000 U.S. employees and over 2,500 industry experts for the ranking.

What are the three main categories BD (BDX) was evaluated on for the Fortune innovation ranking?

Companies were evaluated on product innovation, process innovation, and innovation culture.

How does BD's innovation strategy impact its global healthcare presence?

BD's innovation strategy enables them to manufacture medical products at scale, serving billions of patients globally through continuous improvement and addressing unmet healthcare needs.

What is BD Excellence and how does it relate to the company's innovation?

BD Excellence is the company's culture of continuous improvement that helps drive innovation in medical product manufacturing and customer service delivery.
Becton Dickinson & Co

NYSE:BDX

BDX Rankings

BDX Latest News

BDX Stock Data

66.57B
285.49M
0.56%
93.73%
1.02%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
FRANKLIN LAKES